]i) were assessed in fura 2-loaded OK cells expressing the vector (VOK), RNCX (ROK), and SNCX (SOK). Baseline [Ca 2ϩ ]i was 98 Ϯ 20 nM (n ϭ 12) in VOK and was significantly lower in ROK (44 Ϯ 5 nM; n ϭ 12) and SOK (47 Ϯ 13 nM; n ϭ 12) cells. ATP at 100 M increased [Ca 2ϩ ]i by 189 Ϯ 55 nM (n ϭ 12), 21 Ϯ 9 nM (n ϭ 12), and 69 Ϯ 18 nM (n ϭ 12) in VOK, ROK, and SOK cells, respectively. ATP (1 mM) or bradykinin (0.1 mM) caused large increases in [Ca 2ϩ ]i and ROK but not SOK cells were much more efficient in reducing [Ca 2ϩ ]i back to baseline levels. Parental Sprague-Dawley rat mesangial cells express both RNCX (SDRNCX) and SNCX (SDSNCX). SDRNCX and RNCX are identical at every amino acid residue, but SDSNCX and SNCX differ at amino acid 218 where it is isoleucine in SDSNCX and not phenylalanine. OK cells expressing SD-SNCX (SDSOK) reduced ATP (1 mM)-induced [Ca 2ϩ ]i increase back to baseline at a rate equivalent to that for ROK cells. PKC downregulation significantly attenuated the rate at which ROK and SDSOK cells reduced ATP-induced [Ca 2ϩ ]i increase but had no effect in SOK cells. The reduced efficiency of SNCX to regulate [Ca 2ϩ ]i is attributed, in part, to the isoleucine-to-phenylalanine mutation at amino acid 218. sodium/calcium exchanger; mesangial cells; hypertension IN RECENT STUDIES, Na ϩ /Ca 2ϩ exchange (NCX) activity has been shown to exist in renal afferent and efferent arterioles and cultured mesangial cells (2, 20, 23, 33) . It most likely plays an important role in the regulation of cytosolic calcium concentration ([Ca 2ϩ ] i ) by serving as a Ca 2ϩ efflux pathway. Studies in vascular smooth muscle (36) have further suggested that the exchanger has an important role in lowering agonist-induced elevations in [Ca 2ϩ ] i and it is possible that it serves a similar function in the renal microcirculation. We extended this proposal by suggesting that this process may also involve the activation of protein kinase C (PKC). Phorbol esters, which activate PKC, enhance exchanger activity in afferent arterioles and mesangial cells and this may be due to PKC-induced translocation of the exchanger to the plasma membrane (20). It is also well known that vasoconstrictive agonists, which elevate [Ca 2ϩ ] i , also activate PKC through the Ca 2ϩ -diacylglycerol pathway. Although PKC can have multiple cellular effects, one effect may be to enhance NCX, which then serves to return agonist-induced elevations in [Ca 2ϩ ] i back to baseline levels. In other studies, we found that this Na ϩ /Ca 2ϩ exchanger pathway may be defective in the Dahl/Rapp salt-sensitive (S) rat (33), a genetic model of salt-dependent hypertension (3, 30). Both freshly dissected afferent arterioles from the Dahl/Rapp salt-resistant (R) rats and from rabbit kidneys as well as cultured mesangial cells from R rats all responded to the phorbol ester PMA with enhanced NCX activity (2, 8, 20, 23, 33) . In afferent arterioles and cultured mesangial cells from S rats, PMA failed to increase Na ϩ /Ca 2ϩ exchanger activity. In S mesangial cells, PMA also failed to stimulate translocation of the exchanger to the plasma membrane, whereas in R mesangial cells, PMA promoted translocation (20) .
]i) were assessed in fura 2-loaded OK cells expressing the vector (VOK), RNCX (ROK), and SNCX (SOK). Baseline [Ca 2ϩ ]i was 98 Ϯ 20 nM (n ϭ 12) in VOK and was significantly lower in ROK (44 Ϯ 5 nM; n ϭ 12) and SOK (47 Ϯ 13 nM; n ϭ 12) cells. ATP at 100 M increased [Ca 2ϩ ]i by 189 Ϯ 55 nM (n ϭ 12), 21 Ϯ 9 nM (n ϭ 12), and 69 Ϯ 18 nM (n ϭ 12) in VOK, ROK, and SOK cells, respectively. ATP (1 mM) or bradykinin (0.1 mM) caused large increases in [Ca 2ϩ ]i and ROK but not SOK cells were much more efficient in reducing [Ca 2ϩ ]i back to baseline levels. Parental Sprague-Dawley rat mesangial cells express both RNCX (SDRNCX) and SNCX (SDSNCX). SDRNCX and RNCX are identical at every amino acid residue, but SDSNCX and SNCX differ at amino acid 218 where it is isoleucine in SDSNCX and not phenylalanine. OK cells expressing SD-SNCX (SDSOK) reduced ATP (1 mM)-induced [Ca 2ϩ ]i increase back to baseline at a rate equivalent to that for ROK cells. PKC downregulation significantly attenuated the rate at which ROK and SDSOK cells reduced ATP-induced [Ca 2ϩ ]i increase but had no effect in SOK cells. The reduced efficiency of SNCX to regulate [Ca 2ϩ ]i is attributed, in part, to the isoleucine-to-phenylalanine mutation at amino acid 218. sodium/calcium exchanger; mesangial cells; hypertension IN RECENT STUDIES, Na ϩ /Ca 2ϩ exchange (NCX) activity has been shown to exist in renal afferent and efferent arterioles and cultured mesangial cells (2, 20, 23, 33) . It most likely plays an important role in the regulation of cytosolic calcium concentration ([Ca 2ϩ ] i ) by serving as a Ca 2ϩ efflux pathway. Studies in vascular smooth muscle (36) have further suggested that the exchanger has an important role in lowering agonist-induced elevations in [Ca 2ϩ ] i and it is possible that it serves a similar function in the renal microcirculation. We extended this proposal by suggesting that this process may also involve the activation of protein kinase C (PKC). Phorbol esters, which activate PKC, enhance exchanger activity in afferent arterioles and mesangial cells and this may be due to PKC-induced translocation of the exchanger to the plasma membrane (20) . It is also well known that vasoconstrictive agonists, which elevate [Ca 2ϩ ] i , also activate PKC through the Ca 2ϩ -diacylglycerol pathway. Although PKC can have multiple cellular effects, one effect may be to enhance NCX, which then serves to return agonist-induced elevations in [Ca 2ϩ ] i back to baseline levels. In other studies, we found that this Na ϩ /Ca 2ϩ exchanger pathway may be defective in the Dahl/Rapp salt-sensitive (S) rat (33) , a genetic model of salt-dependent hypertension (3, 30) . Both freshly dissected afferent arterioles from the Dahl/Rapp salt-resistant (R) rats and from rabbit kidneys as well as cultured mesangial cells from R rats all responded to the phorbol ester PMA with enhanced NCX activity (2, 8, 20, 23, 33) . In afferent arterioles and cultured mesangial cells from S rats, PMA failed to increase Na ϩ /Ca 2ϩ exchanger activity. In S mesangial cells, PMA also failed to stimulate translocation of the exchanger to the plasma membrane, whereas in R mesangial cells, PMA promoted translocation (20) .
To determine whether this difference between R and S rats was due to intrinsic differences in the exchanger protein, NCX was cloned from cultured mesangial cells from R and S rats (33) . The clone from S rats denoted SNCX and from R rats denoted RNCX differs at the amino acid level. One difference occurs at amino acid residue 218, where it is isoleucine in RNCX but is phenylalanine in SNCX. The significance of this single amino acid difference is presently unknown. However, it may affect the regulation of SNCX since this difference occurs in a region that is 43% homologous to a region (amino acids 308-330) of the Na ϩ -K ϩ -ATPase that is responsible for binding Ca 2ϩ (25) . The other difference between RNCX and SNCX occurs within the cytosolic loop at the alternative splice site. This site is encoded by six different exons denoted A-F (16, 29) . In the RNCX clone, the alternative splice site is encoded by exons B and D, and in SNCX it is encoded by exons B, D, and F (33) . Although there is some indication that the alternative splice site may be important in NCX regulation (27) , the exact consequence of the differences in exons expressed by these two clones at this site remains unknown.
RNCX and SNCX were expressed in an opossum kidney cell line (OK-PTH) that does not express endogenous exchanger activity. It was found that the exchanger activity of RNCX but not SNCX was enhanced by PMA (33) . Thus, the PKC-Na ϩ /Ca 2ϩ exchanger pathway in the S rat appears to be defective at the level of the exchanger protein.
The Dahl/Rapp rat model of hypertension is characterized by a marked increase in blood pressure, decreased renal blood flow, and a progressive fall in glomerular filtration rate when S rats are placed on an 8% NaCl diet (3) . It has been suggested that this progressive renal vasoconstriction is due to a dysregulation of [Ca 2ϩ ] i in contractile elements of the renal microcirculation of the S rat. One possible explanation for this derangement in [Ca 2ϩ ] i could be defective PKC regulation of the Na ϩ /Ca 2ϩ exchanger. However, whether expression of RNCX vs. SNCX actually results in differences in the regulation of [Ca 2ϩ ] i has not yet been addressed. Therefore, the purpose of these studies was to express RNCX and SNCX in identical cellular environments (OK-PTH cells) and to determine whether these two isoforms differ in their ability to help regulate [Ca 2ϩ ] i in response to agonist-induced elevations in [Ca 2ϩ ] i . Because RNCX and SNCX are both expressed in mesangial cells of Sprague-Dawley rats, these results were also compared with those obtained for OK-PTH cells expressing the SNCX that was cloned from mesangial cells of Sprague-Dawley rats (SDSNCX). For these studies, we used ATP to elevate [Ca 2ϩ ] i via the activation of purinergic receptors; several isotypes of this receptor family were confirmed to be present in OK-PTH cells. In addition, bradykinin was also used to elevate [Ca 2ϩ ] i to ensure that the findings obtained with ATP were not peculiar to purinergic receptor pathways.
METHODS
Cell cultures. Opossum proximal tubule kidney cells (OK-PTH, ATCC) were grown in MEM (Gibco Laboratories, Grand Island, NY) supplemented with 10% Fetalclone III (Cellgro), 240 g/ml L-glutamine (Gibco), 82 U/ml penicillin, and 82 g/ml streptomycin (Sigma) in a humidified atmosphere under 95% air-5% CO 2 at 37°C. Media were changed twice a week, and cells were routinely passaged 72 h after seeding. Each OK-PTH cell lot was used for no more than 30 passages.
Transfection of OK-PTH cells with RNCX, SNCX, and SDSNCX. OK-PTH cells were transfected with pCDNA3.1/ V5-His-TOPO (Invitrogen) containing RNCX (pCDNA3.1-RNCX), SNCX (pCDNA3.1-SNCX), or SDSNCX (pCDNA3.1-SDSNCX) cDNA using lipofectin (BRL) according to the manufacturer's instructions. Transfectants were selected for using geneticin at 500 g/ml for 3 wk. After 3 wk, transfected cells were incubated in the presence of 500 M Ca 2ϩ and 20 M ionomycin for 30 min, washed, and resuspended in complete media. This maneuver stimulates a significant rise in were grown to 80% confluency in 100-mm cell culture dishes with MEM supplemented with 10% Fetalclone III and 82 g/ml penicillin/streptomycin. Cells were harvested with a cell scraper and incubated in media containing 24 M fura 2-AM (TEF Labs, Austin, TX) for 1 h at 37°C to allow loading of the dye into cells. Fura 2-loaded cells were pelleted at 700 g for 3 min and resuspended in Ringer solution (150 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1.6 mM Na2HPO4, 0.4 mM NaH 2PO4, 5 mM D-glucose, 1.5 mM CaCl2, 10 mM HEPES).
A small quantity of cells was then transferred to a chamber that was mounted on an inverted microscope. After several minutes, OK cells would settle to the bottom of the chamber and adhere to the coverslip that formed the chamber's bottom. After a period of 5 to 10 min, it was possible to perfuse the chamber even at high flow rates with the cells remaining attached to the coverslip. Single-cell [Ca 2ϩ ]i measurements were performed using dual-excitation wavelength fluorescence microscopy (Photon Technologies, Princeton, NJ) with a Leitz compact photometer that had been converted to perform photon counting. An adjustable photometery window was placed over a single cell with magnification of ϫ400 using an Olympus X40 UVFL lens. Excitation wavelengths were set at 340 and 380 nm and alternated at 25 Hz. Emission wavelength was set at 510 nm, with data collection at a rate of 5 points/s using PTI software. Background corrections were made before the experimental measurements.
Baseline fura 2 ratios were measured for at least 100 s in cells that were bathed in Ringer solution at a rate of 1.7 ml/min. Cells were discarded if the baseline drifted either up or down. After a stable baseline reading was obtained, either 100 M or 1 mM ATP or 100 M bradykinin was added to the chamber at a rate of 1.7 ml/min to elevate [Ca 2ϩ ]i. The fura 2 ratio was monitored continuously before, during, and after addition of ATP or bradykinin until the ratio returned to a stable baseline. All solutions had a pH of 7.4 with temperature maintained at 37°C. In addition, there was no evidence of dye leakage throughout the experiment.
Effect of PKC downregulation on Na ϩ /Ca 2ϩ exchanger activity. Previous studies showed that PKC plays an important role in the activation of NCX. To examine the role that PKC might play in the regulation of RNCX, SNCX, or SD-SNCX, cells expressing RNCX (ROK), SNCX (SOK), or SD-SNCX (SDSOK) were treated with 300 nM PMA for 24 h to downregulate PKC before single-cell [Ca 2ϩ ]i measurements.
PMA was added directly to the culture media, and cells were maintained in the incubator throughout the 24-h period. 
where Kd is the effective dissociation constant of fura 2 and has a value of 224 nM, R is the fluorescence ratio obtained at 340/380 nm, R min and Rmax are the ratios in absence and presence of Ca 2ϩ , respectively, and Sf2 and Sb2 are the emissions at 380 nm in the absence and presence of Ca 2ϩ , respectively. VOK, ROK, SDSOK, or SOK cells were loaded with 24 M fura 2 for 1 h, followed by resuspension in Ringer solution. Calibration was accomplished after permeabilization of the cells with 5 M ionomycin and measurement of fluorescence at both wavelengths, 340 and 380 nm, under Ca 2ϩ -free (in 2 mM EGTA) or Ca 2ϩ -saturated (in 0.25 M CaCl2) conditions to obtain Rmin, Rmax, Sf2, and Sb2.
Genomic DNA sequencing. The cDNAs for RNCX and SNCX show differences at amino acid 218, where it is isoleucine in RNCX but is phenylalanine in SNCX, and at the alternative splice site, where it is encoded by exons B and D and B, D, and F in RNCX and SNCX, respectively. To address the question of whether the mutation observed at the cDNA level occurs at the genomic level, genomic DNA was isolated from kidneys of S and R Dahl/Rapp rats using the Easy-DNA kit (Invitrogen) according to manufacturer's instructions. A 100-ng aliquot of the genomic DNA was used to amplify the NH 2 terminus of the Na ϩ /Ca 2ϩ exchanger gene using a forward and a reverse primer (5Ј-gagaggatccgacaggcggcttctctttt-3Ј/5Ј-gaggagaattctgcaacccaagcgaacaca-3Ј). PCR was carried out by using the High Fidelity Supermix kit (Invitrogen). With the use of a minicycler (MJ Research), PCR was carried out at 94°C for 2 min, 40 cycles at 94°C for 30 s, 45°C for 30 s, and 68°C for 45 s followed by a long extension time of 10 min at 68°C. Ten microliters of each PCR product were fractionated on a 1% Tris acetate-EDTA gel, and the band was excised and gel purified using Gene Clean (Amersham). A 2-l aliquot of the purified PCR fragment was ligated into pcDNA3.1GFPTOPO using the TOPO TA Cloning Kit (Invitrogen). The entire ligation mix was used to transform Top 10-competent Escherichia coli (Invitrogen) that were subsequently screened (34) , and plasmid was isolated from six positive colonies containing the NH 2 terminus for RNCX or SNCX. The plasmids were sent to SEQWRIGHT (Houston, TX) for sequencing, and the DNASIS Max program (Hitachi Software Engineering) was used for sequence alignments and manipulations.
RESULTS

SNCX and RNCX exchanger levels.
With the use of immunoblot analysis, the level of protein expression in VOK, ROK, and SOK cells was evaluated and the results are shown in Fig. 1 . A low level of NCX protein was detected in VOK cells, and this level was at least 10-fold less than that seen in ROK and SOK cells. We reported in an earlier study that OK-PTH cells did not functionally express the exchanger as evaluated by reverse mode (33) . The important point is that the expression of exchanger protein did not differ between ROK and SOK cells. series of experiments was to perfuse a relatively low concentration of ATP (100 M; at least it is a low concentration for OK-PTH cells) and to assess the ability of the exchanger to extrude this ATP-mediated Ca 2ϩ influx and mobilization. The concentration of ATP and the rate of perfusion were selected based on preliminary experiments that provided the optimal separation of Ca 2ϩ transients between VOK and ROK cells. As shown in the example in Fig. 3A and in the summary in Fig. 3B (Figs. 4D and 5C ). RNCX and SNCX are both expressed in mesangial cells of the parental strain, Sprague-Dawley rat and are designated SDRNCX and SDSNCX, respectively. Although RNCX and SDRNCX are identical at every amino acid residue, SNCX and SDSNCX differ at amino acid 218, where it is isoleucine in SDSNCX but is phenylalanine in SNCX. To assess the effect of this single amino acid difference, OK cells were transfected with SDSNCX, and the ability of OK cells expressing SDSNCX (SDSOK) to reduce the ATP (1 mM)-induced [Ca 2ϩ ] i increase was assessed as previously described. We found that SDSOK cells reduced the ATP-induced [Ca 2ϩ ] i increase back to baseline level at a rate that was significantly greater than that for SOK but equivalent to that for ROK (Fig. 4, B,  C, and D) .
PKC regulation. Previous studies showed that basal exchanger activity is similar between RNCX and SNCX isoforms and that PKC activation leads to enhanced exchanger activity in OK-PTH cells that expressed RNCX but not SNCX (33) . Because, in the presence of extracellular ATP, exchanger activity was higher in ROK and SDSOK cells compared with SOK cells, this difference could be due to ATP activation of PKC. To test this possibility, ROK, SDSOK, and SOK cells were either left untreated or pretreated with 300 nM PMA for 24 h, a maneuver that is known to downregulate PKC activity. As shown in Fig. 6 , A-C, there is a distinct difference in the effects of PKC downregulation in ROK and SDSOK vs. SOK cells. As shown in Fig. 6, A and B, the rate of return of [Ca 2ϩ ] i in ROK and SDSOK cells, after administration of ATP, was dramatically reduced with PKC inhibition. However, the rate of return of [Ca 2ϩ ] i in SOK cells (Fig. 6C) was not greatly affected by prior treatment with PMA. As shown in the summary in Fig. 6D , there was a highly significant decrease in the rate of Ca 2ϩ recovery with PKC downregulation in ROK and SDSOK cells but not in SOK cells.
Genomic DNA sequencing. The amino acid difference between RNCX and SNCX at residue 218 occurred as the result of an A-to-T transversion that changed the codon for isoleucine (ATT) to that for phenylalanine (TTT). To determine whether this difference occurs at the genomic level, the coding region of the Na ϩ /Ca 2ϩ exchanger gene from nucleotide 1 to 747 was sequenced in both directions using genomic DNAs isolated from kidneys of S and R Dahl/Rapp rats. The sequence data (Fig. 7) show that the difference between RNCX and SNCX that we observed in the cDNAs does not occur at the DNA level.
DISCUSSION
The Na ϩ /Ca 2ϩ exchanger (NCX) is a 120-kDa transmembrane protein that consists of five NH 2 -terminal and four COOH-terminal membrane-spanning domains and a cytosolic loop that comprises over 50% of the protein (11) . There are at least four different NCX exchangers encoded by separate genes (18, 24, 26) . To date, only NCX1 (which is also the cardiac isoform) has been demonstrated to occur in the tubules (4, 5), blood vessels (2, 23) , and mesangial cells of the kidney (2, 20, 22, 33) . RNCX (NCX1.3) and SNCX (NCX1.7) were previously cloned from mesangial cells of the Dahl/ Rapp R and S rat, respectively (33) . They are 100% homologous at the COOH-terminal membrane-spanning domains and nearly identical in the NH 2 -terminal membrane-spanning domains except for a single amino acid difference at residue 218, where it is isoleucine in RNCX and phenylalanine in SNCX. It should be noted that all other NCX1 isoforms that have been cloned have isoleucine at this site. Both RNCX and SNCX are also highly homologous in the large cytoplasmic loop except at the alternative splice site where RNCX is encoded by exons B and D, whereas SNCX is encoded by exons B, D, and F. Thus, these differences in amino acid sequence may cause the lack of PKC sensitivity of the Na ϩ /Ca 2ϩ exchanger in afferent arterioles and cultured mesangial cells from the Dahl/Rapp S rat. This PKC sensitivity of RNCX but not SNCX could also be clearly demonstrated when these two isoforms were cloned into OK-PTH cells.
In previous studies, exchanger activity in OK-PTH cells expressing RNCX (ROK) and SNCX (SOK) was examined using a 45 Ca 2ϩ influx assay that involves sodium-loading cells followed by extracellular sodium removal. This stimulates the reverse-mode NCX (Ca 2ϩ entry and Na exiting the cell) that is opposite to how the exchanger normally operates under physiological conditions. Nevertheless, these studies indicated that 1) nontransfected OK-PTH cells had virtually no exchanger activity; 2) basal exchanger activity was similar in ROK and SOK cells; 3) RNCX activity increased with acute PMA treatment; and 4) SOK exchanger activity was insensitive to PKC activation or PKC downregulation by 24-h pretreatment with PMA. However, these studies did not provide insights into whether this difference in PKC sensitivity would have any consequences regarding the role of these exchangers in the regulation of [Ca 2ϩ ] i . It has been suggested that NCX is involved in the extrusion of Ca 2ϩ after agonist-induced elevations in [Ca 2ϩ ] i (6) . This issue was addressed in a recent study by Slodzinski and Blaustein (31) , in which knockdown of exchanger activity was achieved by pretreatment with antisense oligodeoxynucleotides of NCX. They found that recovery from elevations in [Ca 2ϩ ] i was substantially prolonged in cells that were treated with antisense compared with control cells. This exchangermediated reduction in [Ca 2ϩ ] i represents the forward mode of the exchanger and more closely resembles the physiological role of NCX in [Ca 2ϩ ] i homeostasis. In the present study, we used a similar approach except that we compared the regulation of [Ca 2ϩ ] i in cells that were either vector transfected or transfected with the RNCX, SNCX, or SDSNCX clone. In this manner, we could directly determine whether there were differences in [Ca 2ϩ ] i regulation between RNCX and SNCX and whether those differences could be attributed to the differences at the amino acid level.
Initial studies were performed to measure baseline [Ca 2ϩ ] i in these three cell types. We found that cells expressing Na ϩ /Ca 2ϩ exchanger isoforms had lower baseline [Ca 2ϩ ] i compared with nontransfected cells. [Ca 2ϩ ] i regulation is complex and is the result of an ensemble of receptors, channels, and transporters located at plasma and intracellular membrane sites. Nevertheless, the notion has been that at the plasma membrane, Ca 2ϩ -ATPase, a high-affinity and low-ca- pacity Ca 2ϩ -extrusion mechanism, was important for setting the resting [Ca 2ϩ ] i , whereas NCX, a low-affinity and high-capacity Ca 2ϩ -extrusion mechanism, primarily extruded Ca 2ϩ when [Ca 2ϩ ] i was elevated above baseline levels (1, 6, 9) . Our studies indicate that NCX does contribute to the nonstimulated level of [Ca 2ϩ ] i at least in this cell type and under these conditions.
In most studies of agonist-induced alterations in [Ca 2ϩ ] i , the initial paradigm is to invoke Ca 2ϩ transients by rapidly applying sufficient hormone or agent to achieve a maximum [Ca 2ϩ ] i spike. In the present studies, we wanted to examine the ability of the exchanger clones to handle a submaximal stimulus that would cause Ca 2ϩ entry and mobilization. We found that OK-PTH cells express P2X4, P2X5, and P2Y2 (data not shown) and that a concentration of 100 M ATP produced optimal discrimination between the results obtained in the vector-transfected group vs. those obtained in ROK cells. In other cell types, 100 M ATP may produce maximal effects; however, this may depend on, among other things, the number of P2 receptors that are on the cell membrane. The important point is that during this exposure to micromolar levels of ATP, cells expressing NCX were much better able to prevent or minimize the increase in [Ca 2ϩ ] i . Also, a major finding of this study is that ROK cells were much better at buffering changes in [Ca 2ϩ ] i compared with SOK cells. Because these cell lines express comparable levels of NCX (Fig. 1) , this is direct evidence supporting the notion that the SNCX isoform is not as efficient or as effective in regulating [Ca 2ϩ ] i . Other studies were performed to assess the ability of RNCX and SNCX to extrude Ca 2ϩ after maximal agonist-induced increases in [Ca 2ϩ ] i . Similar to what was observed in the preceding experiments, the rate at which Ca 2ϩ declined after administration of 1 or 0.1 mM ATP or bradykinin, respectively, was slower and took longer to occur in SOK cells vs. ROK cells. These results further support our conclusion that SNCX is much less efficient in regulating agonist-induced alter- Genomic DNA sequence of SNCX shows ATT(I) but not TTT(F) at nucleotides 652-654. To determine whether the isoleucine-to-phenylalanine mutation at amino acid 218 (shown in bold) in SNCX occurs at the genomic level, genomic DNA was isolated from kidneys of salt-sensitive and salt-resistant rats and the nucleotide sequence corresponding to the NH2 terminus of the Na ϩ /Ca 2ϩ exchanger was PCR amplified using Na ϩ /Ca 2ϩ exchanger-specific primers and sequenced. The nucleotide sequence of SNCX and RNCX spanning nucleotides 631-657 (amino acids 211-219) is shown for RNCX and SNCX cDNA (c) and genomic DNA (g). ] i at a rate that was comparable to that for cells expressing RNCX. Thus, the isoleucine-to-phenylalanine change in SNCX appeared to contribute, in part, to the inability of this isoform to regulate agonist-induced elevations in [Ca 2ϩ ] i levels. Because of the profound effect of the isoleucine-tophenylalanine difference at amino acid 218 on the ability of SNCX to regulate agonist-induced [Ca 2ϩ ] i increase, we next determined whether the mutation occurred at the genomic level. This was accomplished by sequencing the coding region of the Na ϩ /Ca 2ϩ exchanger gene from genomic DNA of S and R Dahl/Rapp rats spanning nucleotides 1 to 747. Our data showed that the A-to-T transversion in the SNCX cDNA did not occur at the genomic level. However, because we took great care in eliminating PCR artifacts in our original study where we sequenced these isoforms, we feel confident that this mutation is not likely to be a PCR artifact. We suggest the possibility that this mutation might occur in the S mesangial cell as a result of mRNA editing. Although rare, studies have shown that this does occur in the eukaryotic cell and affects a number of proteins including Apo B (32), glutamate receptor (17) , and oxytocin receptor (7) . Apo B has two isoforms, Apo B-100 and Apo B-48. Apo B-100 is a 512-kDa protein that is synthesized in the liver, whereas Apo B-48 is a 240-kDa protein that consists of the NH 2 terminus of Apo B-100. Apo B-48 is synthesized in the small intestine, is developmentally regulated, and is the result of a CAA-to-UAA mutation that generates this truncated form of Apo B. The glutamate receptor has also been shown to undergo mRNA editing, which results in a Q-to-R mutation that arises as the result of a CAG-to-CGG codon change. Studies showed that differences in oxytocin receptor mRNA sequences for different oxytocin receptor populations in the endometrium are due to mRNA editing. mRNA editing of the oxytocin receptor transcripts leads to differences in the observed responses to an oxytocin challenge. Therefore, although rare, the possibility exists that NCX mRNA editing may occur in addition to alternative splicing in mesangial cells of the S Dahl/ Rapp rat.
Presently, the role that PKC plays in the activation of the Na ϩ /Ca 2ϩ exchanger is not clearly understood. Our laboratory demonstrated that PKC activates NCX in the renal microcirculation of rabbits and normotensive rats (8) and in the cloned exchanger RNCX (33) . Also, work by Vigne et al. (35) found that phorbol esters stimulated the exchanger in cultured aortic smooth muscles. However, other studies in human mesangial cells by Mene et al. (21) failed to demonstrate enhanced reverse-mode NCX. In studying the regulation of NCX1, 2, and 3, Linck et al. (19) found that NCX1 and 3 showed modest stimulation by both PKA and PKC agonists. Exchanger activity appeared to be much more sensitive to PMA downregulation. Finally, Iwamoto et al. (12) demonstrated that activation of PKC by agonists enhanced exchanger activity and phosphorylation of NCX1 (12) (13) (14) , which occurred exclusively on serine residues. Mutational analysis, however, indicated that activation of the exchanger did not require direct phosphorylation of serine residues by PKC but did require the presence of the cytosolic loop (12) . Thus, the bulk of the present evidence favors PKC activation of NCX1, but the mechanism by which this occurs remains unclear. Our laboratory proposed that PKC may induce translocation of the exchanger, but whether this is responsible for enhanced exchanger activity has also not been established.
The role of PKC in enhancing exchanger activity may be important based on the following scheme. The binding of a vasoactive hormone to its receptor triggers the activation of phospholipase C, which hydrolyses phosphatidyl inositol 4,5-bisphosphate and elevates diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP 3 In the present studies, this scenario was, in part, tested by 24-h pretreatment with PMA, a maneuver that is known to downregulate PKC activity. Studies in other cell systems (28) showed that extracellular ATP via P2 receptors does increase PKC activity. We demonstrated that inhibition of PKC activity greatly affected the abilities of ROK and SDSOK cells to rapidly return [Ca 2ϩ ] i to control levels. In contrast, PKC inhibition did not affect the rate of return in [Ca 2ϩ ] i in SOK cells. It should be mentioned that the Ca 2ϩ transients obtained in the presence of PKC inhibition were much more labile and variable compared with cells that were not treated with PMA. This may reflect the fact that PKC has multiple cellular effector sites including effects on other cellular Ca 2ϩ regulatory processes. Nevertheless, these results are in agreement with our previous work examining reverse-mode NCX in ROK and SOK cells (33) . They extend this previous work by suggesting that this difference in PKC sensitivity may have important consequences in terms of the cellular regulation of [Ca 2ϩ ] i . Furthermore, these results indicate that insensitivity of SNCX to PKC may be attributed, in part, to the single amino acid difference at residue 218. However, future mutational analysis is needed to determine the exact mechanism that underlies the basis of SNCX insensitivity to PKC. In conclusion, we found that an isoform of the Na ϩ / Ca 2ϩ exchanger that was cloned from mesangial cells of the Dahl/Rapp S rat has an impaired ability to regulate agonist-induced changes in [Ca 2ϩ ] i . The cause of this reduced efficiency in Ca 2ϩ extrusion appears to be due to a defect in PKC activation of SNCX, which may be attributed, in part, to a single amino acid mutation at amino acid 218. We suggest that this reduced ability of the Na ϩ /Ca 2ϩ exchanger to regulate [Ca 2ϩ ] i in the renal microcirculation may be responsible, in part, for the increased vascular resistance and reduced glomerular filtration rate that are hallmarks of this form of hypertension.
